HomeCompareQBIG vs JNJ

QBIG vs JNJ: Dividend Comparison 2026

QBIG yields 5.87% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QBIG wins by $9.4K in total portfolio value
10 years
QBIG
QBIG
● Live price
5.87%
Share price
$34.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.4K
Annual income
$852.52
Full QBIG calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — QBIG vs JNJ

📍 QBIG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQBIGJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QBIG + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QBIG pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QBIG
Annual income on $10K today (after 15% tax)
$498.53/yr
After 10yr DRIP, annual income (after tax)
$724.64/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, QBIG beats the other by $21.03/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QBIG + JNJ for your $10,000?

QBIG: 50%JNJ: 50%
100% JNJ50/50100% QBIG
Portfolio after 10yr
$24.7K
Annual income
$840.15/yr
Blended yield
3.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

QBIG
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QBIG buys
0
JNJ buys
0
No recent congressional trades found for QBIG or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQBIGJNJ
Forward yield5.87%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$29.4K$20.0K
Annual income after 10y$852.52$827.78
Total dividends collected$7.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QBIG vs JNJ ($10,000, DRIP)

YearQBIG PortfolioQBIG Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,287$586.51$10,676$355.77+$611.00QBIG
2$12,695$618.66$11,407$389.39+$1.3KQBIG
3$14,234$650.35$12,198$426.53+$2.0KQBIG
4$15,912$681.49$13,056$467.62+$2.9KQBIG
5$17,738$711.98$13,987$513.12+$3.8KQBIG
6$19,721$741.75$14,998$563.56+$4.7KQBIG
7$21,873$770.74$16,098$619.52+$5.8KQBIG
8$24,203$798.90$17,295$681.69+$6.9KQBIG
9$26,723$826.17$18,599$750.82+$8.1KQBIG
10$29,446$852.52$20,022$827.78+$9.4KQBIG

QBIG vs JNJ: Complete Analysis 2026

QBIGStock

The Fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective through exposure to the top companies in the Nasdaq-100 Index (the “Nasdaq-100”), as represented in the Nasdaq-100 Mega Index (the “Index”). The Nasdaq-100 consists of securities of 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market LLC based on market capitalization. The Index is a subset of the Nasdaq-100, comprising approximately the top 45% by weight of Nasdaq-100 companies, but not exceeding 47%. The Fund seeks to track the performance of those companies.

Full QBIG Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this QBIG vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QBIG vs SCHDQBIG vs JEPIQBIG vs OQBIG vs KOQBIG vs MAINQBIG vs ABBVQBIG vs MRKQBIG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.